Why it’s hard to stomach big pharma’s complaints about Covid vaccine patent waivers


N

o, nay, never, was the reaction of the pharmaceutical industry to America’s potentially game-changing move to back a vaccine patent waiver in an attempt to improve global supplies.

The argument of the drug companies is: innovation would be stifled, threatening the development of future treatments, and that would be disastrous for patients.

Do they have a point?



Source link

Related posts